Anacor Pharmaceuticals Announces Third Quarter 2011 financial Results ... MarketWatch (press release) In addition, Anacor is developing AN2718 As a topical antifungal wares candidate for the attention of onychomycosis and cutis fungal infections, and AN2898 as a topical medicine product candidate for the treatment of psoriasis and atopic ... and more » Link To Article
No comments:
Post a Comment